Abstract
Purpose
The efficacy of 20-gauge and 23-gauge vitrectomy system was investigated in primary vitrectomy for rhegmatogenous retinal detachment.
Methods
Eyes that underwent primary vitrectomy without scleral buckling for the treatment of rhegmatogenous retinal detachment were followed up at least 6 months and were reviewed retrospectively. Anatomic results, functional outcomes, operation time and complications were compared between 20-gauge and 23-gauge groups.
Results
Among 59 eyes of 59 patients, the 20-gauge group had 29 eyes of 29 patients and 23-gauge group had 30 eyes of 30 patients. Anatomic success after a single operation was obtained in 23 eyes (79.3%) of the 20-gauge group and 28 eyes (93.3%) of the 23-gauge group. Recurrence occurred in 6 eyes (20.7%) in the 20-gauge and in 2 eyes (6.6%) in the 23-gauge group. Retinal reattachment in all of these eyes was obtained through reoperation. Visual acuity improved logMAR 0.2 or more in 19 eyes (65.5%) of the 20-gauge group and 20 eyes (66.7%) of the 23 gauge group (p=0.153, 0.215). The average operation time of the 23-gauge group was 80.2 minutes, which was significantly shorter than the 94.8 minutes of the 20-gauge group (p=0.008). Transient ocular hypertension and progression of lens opacity were the most common complications in the both groups.
References
1. Gonin J. Treatment of detached retina by searing the retinal tears. Arch Ophthalmol. 1930; 4:621–5.
2. Custodis E. Importance of the vitreous body in retina surgery with special emphasis on reoperations. 1st ed.St. Louis: C.V. Mosby;1960. p. 75–8.
3. Machemer R, Buettner H, Norton EW, Parel JM. Vitrectomy. A pars plana approach. Trans Am Acad Ophthalmol Otolaryngol. 1971; 75:813–6.
4. Han DP, Mohsin NC, Guse CE, et al. Comparison of pnuematic retinopexy and scleral buckling in management of primary rhegmatogenous retinal detachment. Am J Ophthalmol. 1998; 126:658–68.
5. Park JL, Kim SD, Yun IH. A clinical study of the rhegmatogenous retinal detachment. J Korean Ophthalmol Soc. 2003; 43:1015–24.
6. Kang SW, Kim SW. The Korean Retina Society, Preference for treatment modalities of simple rhegmatogeonous retinal detachment in Korea. J Korean Ophthalmol Soc. 2002; 43:1179–85.
7. Fujii GY, De Juan E Jr, Humayun MS, et al. A new 25-gauge instrument system for transconjunctival sutureless vitrectomy surgery. Ophthalmology. 2002; 109:1807–13.
9. Fine HF, Iranmanesh R, Iturralde D, Spaide RF. Outcomes of 77 Consecutive Cases of 23-Gauge Transconjunctival Vitrectomy Surgery for Posterior Segment Disease. Ophthalmology. 2007; 114:1197–200.
10. Michels RG, Wilkinson CP, Rice TA. Retinal detachment. 1st ed.St. Louis: Mosby;1990. p. 917–58.
11. American Academy of Ophthalmology. Information statement: the repair of retinal detachment. Ophthalmology. 1990; 97:1562.
12. Escoffery RF, Olk RJ, Grand MG, Boniuk I. Vitrectomy without scleral buckling for primary rhegmatogenous retinal detachment. Am J Ophthalmol. 1985; 99:275–81.
13. Hakin KN, Lavin MJ, Leaver PK. Primary vitrectomy for rhe-gmatogenous retinal detachment. Graefes Arch Clin Exp Ophthalmol. 1993; 231:344–6.
14. Oshima Y, Yamanashi S, Sawa M, et al. Two-year follow-up study comparing primary vitrectomy with scleral buckling for macular-off rhegmatogenous retinal detachment. Jpn J Ophthalmol. 2000; 44:538–49.
15. Sharma YR, Karunanithi S, Azad RV, et al. Functional and anatomic outcome of scleral buckling versus primary vitrectomy in pseudophakic retinal detachment. Acta Ophthalmol Scand. 2005; 83:293–97.
16. Woon WH, Burdon MA, Green WT, Chignell AH. Comparison of pars plana vitrectomy and scleral buckling for uncomplicated rhegmatogenous retinal detachment. Curr Opin Ophthalmol. 1995; 6:76–9.
17. Choi HY, Oum BS. Primary vitrectomy in rhegmatogenous retinal detachment. J Korean Ophthalmol Soc. 1998; 39:121–30.
18. Heimann H, Zou X, Jandeck C, et al. Primary vitrectomy for rhegmatogenous retinal detachment: an analysis of 512 cases. Graefes Arch Clin Exp Ophthalmol. 2006; 244:69–78.
19. Newman DK, Burton RL. Primary vitrectomy for pseudophakic and aphakic retinal detachments. Eye. 1999; 13:635–9.
20. Bartz-Schmidt KU, Kirchhof B, Heimann K. Primary vitrectomy for pseudophakic retinal detachment. Br J Ophthalmol. 1996; 80:346–9.
21. Amato JE, Akdauman L. Incidence of complications in 25-gauge transconjunctival sutureless vitrectomy based on the surgical indications. Ophthalmic Surg Lasers Imaging. 2007; 38:100–2.
22. Gupta OP, Weichel ED, Regillo CD, et al. Postoperative complications associated with 25-gauge pars plana vitrectomy. Ophthalmic Surg Lasers Imaging. 2007; 38:270–5.
23. Charles S. Debating the pros and cons of 23-g vs. 25-g vitrectomy: the pros of 25-g vitrectomy. Retin Physician. 2006; 3:24–5.
Table 1.
Variables | 20 Gauge | 23 Gauge |
---|---|---|
No. of eyes (patients) | 29 (29) | 30 (30) |
Age (years, mean) | 58.7±13.0 | 59.8±9.21 |
Sex (male/female) | 19/10 | 15/15 |
Preoperative visual acuity (logMAR, mean± SD*) | 1.37±1.16 | 1.41±1.19 |
Duration of symptoms (weeks, mean) | 3.27±3.98 | 3.33±4.35 |
Preoperative lens status (No. of eyes) | ||
phakia | 22 | 24 |
pseudophakia | 6 | 5 |
aphakia | 1 | 1 |
High Myopia (No. of eyes) | 4 | 2 |
Follow-up (months, mean) | 14.6±8.2 | 7.8±2.2 |
Table 2.
Status | No. of eyes (%) | p | |
---|---|---|---|
20 Gauge | 23 Gauge | ||
Multiple breaks | 13 (44.8) | 10 (33.3) | 0.14 |
Large breaks (>3 DD*) | 5 (17.2) | 7 (23.3) | 0.22 |
Posterior breaks | 8 (27.6) | 4 (13.3) | 0.11 |
Vitreous hemorrhage | 7 (24.1) | 7 (23.3) | 0.24 |
Macular off detachment | 14 (48.3) | 18 (60.0) | 0.14 |
Detachment of 3 quadrants or more | 4 (13.8) | 7 (23.3) | 0.17 |
Preoperative PVR† | 1 (3.3) | 0.51 |
Table 3.
Table 4.
Time (minutes) | 20 Gauge | 23 Gauge | p |
---|---|---|---|
Operation time (total) | 94.8 | 80.2 | 0.008 |
with cataract operation | 101.0 | 83.5 | 0.04 |
without cataract operation | 89.7 | 69.3 | NA* |
Table 5.
No. of eyes (%) | p | ||
---|---|---|---|
20 Gauge | 23 Gauge | ||
Single operation* | 23 (79.3) | 28 (93.3) | 0.09 |
Recurrence | 6 (20.7) | 2 (6.6) | 0.07 |
Causes | |||
New break | 5 | 2 | 0.74 |
PVR | 1 | 0 | 0.74 |
Final operation† | 29 (100.0) | 30 (100.0) |
Table 6.
Duration | BCVA† (logMAR) | BCVA improvement, No. of eyes (%) | ||||
---|---|---|---|---|---|---|
20 Gauge | 23 Gauge | 20 Gauge | 23 Gauge | |||
Mean± SD* | p | More than 0.2 (logMAR) | p | |||
Preoperative | 1.37±1.16 | 1.41±1.19 | 0.876 | |||
1 month | 0.68±0.55 | 0.73±0.64 | 0.767 | 13 (44.8) | 18 (60.0) | 0.106 |
3 months | 0.48±0.39 | 0.54±0.48 | 0.591 | 15 (51.7) | 18 (60.0) | 0.169 |
6 months | 0.48±0.53 | 0.33±0.29 | 0.196 | 18 (62.1) | 21 (70.0) | 0.177 |
Final | 0.25±0.29 | 0.27±0.27 | 0.772 | 19 (65.5) | 22 (73.3) | 0.181 |
Table 7.
Complications | No. of cases (%) | ||
---|---|---|---|
20 Gauge | 23 Gauge | p | |
Cataract progression | 5/9 (55.6) | 0/1 (0.0) | 0.50 |
Transient feathery PSC* | 1/9 (11.1) | 0/0 | 0.99 |
Transient ocular HTN† | 10 (34.4) | 10 (33.3) | 0.22 |
IOL decentration | 1/19 (5.3) | 2/28 (7.1) | |
Hypotony | 1 (3.4) | 0 (0.0) | 0.49 |
Glaucoma | 0 (0.0) | 3 (10.0) | 0.12 |
Iatrogenic tear | 3 (10.3) | 3 (10.0) | 0.33 |
ERM‡ | 1 (3.4) | 2 (6.7) | 0.39 |